SCHEMBL8159848

SCHEMBL8159848

COCCN1CCN(CCNC(C)=O)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
NPSR1 Q6W5P4 1/20 0.47
HSD11B1 P28845 1/20 0.44
CYP2C19 P33261 1/20 0.43
POLB P06746 1/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18850978 0.95 TDP1 (0.50) TDP1MEN1KMT2ANPSR1HSD11B1
SCHEMBL8148004 0.90 TDP1 (0.51) TDP1MEN1KMT2ANPSR1CYP2C19
SCHEMBL4781902 0.87 NPSR1 (0.60) TDP1MEN1KMT2ANPSR1CYP2C19
SCHEMBL13306274 0.87
SCHEMBL8146671 0.83 NPSR1 (0.44) TDP1MEN1KMT2ANPSR1CYP2C19
SCHEMBL18850977 0.81 HTR4 (0.41) TDP1MEN1KMT2AHSD11B1POLB
SCHEMBL2091285 0.81 HDAC2 (0.54) NPSR1CYP2C19POLBCA12CA1
SCHEMBL8153040 0.80 ALDH1A1 (0.49) TDP1MEN1KMT2ANPSR1CYP2C19
SCHEMBL8145102 0.80 TDP1 (0.46) TDP1MEN1KMT2APOLBNPC1
SCHEMBL8139006 0.79 NPSR1 (0.52) TDP1NPSR1CYP2C19CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017075694-A1 ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR SIMON FRASER UNIVERSITY (CA) 2017-05-11 WO disclosed
WO-2008119741-A2 3-IMIDAZOLYL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2008-10-09 WO disclosed